Share and Cite
Glauß, S.; Neumeyer, V.; Hanesch, L.; Marek, J.; Hartmann, N.; Wiedemann, G.M.; Altomonte, J. A Novel Chimeric Oncolytic Virus Mediates a Multifaceted Cellular Immune Response in a Syngeneic B16 Melanoma Model. Cancers 2024, 16, 3405. https://doi.org/10.3390/cancers16193405
Glauß S, Neumeyer V, Hanesch L, Marek J, Hartmann N, Wiedemann GM, Altomonte J. A Novel Chimeric Oncolytic Virus Mediates a Multifaceted Cellular Immune Response in a Syngeneic B16 Melanoma Model. Cancers. 2024; 16(19):3405. https://doi.org/10.3390/cancers16193405
Chicago/Turabian StyleGlauß, Sonja, Victoria Neumeyer, Lorenz Hanesch, Janina Marek, Nina Hartmann, Gabriela M. Wiedemann, and Jennifer Altomonte. 2024. "A Novel Chimeric Oncolytic Virus Mediates a Multifaceted Cellular Immune Response in a Syngeneic B16 Melanoma Model" Cancers 16, no. 19: 3405. https://doi.org/10.3390/cancers16193405
APA StyleGlauß, S., Neumeyer, V., Hanesch, L., Marek, J., Hartmann, N., Wiedemann, G. M., & Altomonte, J. (2024). A Novel Chimeric Oncolytic Virus Mediates a Multifaceted Cellular Immune Response in a Syngeneic B16 Melanoma Model. Cancers, 16(19), 3405. https://doi.org/10.3390/cancers16193405